Showing results (1711-1720 of 1,756) with videos related to
Sort By:
Pageof 176
International Journal of Hygiene and Environmental Health|August 9, 2023
Urinary Amino-PAHs in relation to diesel engine emissions and urinary mutagenicityJunfeng Jim Zhang, Yuxin Zheng, Roel Vermeulen, et al.Journal of Medicinal Chemistry|August 6, 2008
Discovery of novel and long acting muscarinic acetylcholine receptor antagonistsJian Jin, Yonghui Wang, Dongchuan Shi, et al.ACS Medicinal Chemistry Letters|January 8, 2019
3,5-Disubstituted-indole-7-carboxamides as IKKβ Inhibitors: Optimization of Oral Activity via the C3 SubstituentJeffrey K Kerns, Jakob Busch-Petersen, Wei Fu, et al.Environmental and Molecular Mutagenesis|December 11, 2021
Proteomic analysis of serum in workers exposed to diesel engine exhaustMohammad L Rahman, Bryan A Bassig, Yufei Dai, et al.Neoplasia (New York, N.Y.)|November 14, 2025
Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancerChiu-Lien Hung, Wen-Ning Hsu, Tsan-Chun Wang, et al.Journal for Immunotherapy of Cancer|August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkersJarushka Naidoo, Karisa C Schreck, Wei Fu, et al.The New England Journal of Medicine|September 30, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after DiagnosisVallerie V McLaughlin, Marius M Hoeper, David B Badesch, et al.Oncotarget|June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinomaKatherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.Cell Metabolism|July 3, 2025
Microbial riboflavin inhibits ceramide synthase 3 to lower ceramide (d18:1/26:0) and delay colorectal cancer progressionRuize Qu, Yi Zhang, Bora Kim, et al.Journal for Immunotherapy of Cancer|May 22, 2021
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomesJohn A Ligon, Woonyoung Choi, Gady Cojocaru, et al.Pageof 176